TTK Healthcare Ltd

TTK Healthcare Ltd Performance

₹882
Day's Price Range
₹906.75
₹667
52-Week Price Range
₹1125
1 Month Return-3.25 %
3 Month Return-5.72 %
1 Year Return6.1 %

Insights on TTK Healthcare Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years
    img

    In the last 3 years, TTKHLTCARE has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Retail Holding Up
    img

    Retail Investor have increased holdings from 20.85% to 20.94% in Dec 2022 quarter

  • imgPOSITIVE IMPACT

    Price Rise
    img

    In the last 3 years, TTKHLTCARE stock has moved up by 209.4%

  • imgNO EFFECT

    Promoter Holding Unchanged
    img

    Promoters holdings remained unchanged at 74.56% of holdings in Dec 2022 quarter

  • imgNO EFFECT

    Against Peers
    img

    In the last 1 year, Dr Reddys Laboratories Ltd has given 8.4% return, outperforming this stock by 2.3%

  • imgNEGATIVE IMPACT

    MF Holding Down
    img

    Mutual Funds have decreased holdings from 2.21% to 2.17% in Dec 2022 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down
    img

    Foreign Institutions have decreased holdings from 2.37% to 2.32% in Dec 2022 quarter

TTK Healthcare Ltd Shareholding Pattern

InvestorsHoldings %Prev. 4 periods3M change
Promoter Holdings
74.56%
0.00
Foreign Institutions
2.32%
-2.26
Mutual Funds
2.17%
-1.94
Retail Investors
20.94%
0.46
Others
0.01%
4.00

TTK Healthcare Ltd Company Financials

  • Annual
Total Assets
Total Liabilities
Value in ₹ crore

TTK Healthcare Ltd Company Information

TTK Healthcare a TTK group company was incorporated in May 1958 as Orient Pharma and later renamed as TTK Pharma in Nov 81. Some of the other companies belonging to the TTK group include London Rubber TT Textiles TTK Chemicals etc. The company concentrate on pharmaceutical consumer products and hospital care products. The company is the owner of famous Woodwards Gripewater brand. In 1992 the company came out with a rights issue at a premium of Rs 35 aggregating Rs 5.81 cr to finance longterm working capital needs normal capital expenditure and product promotion. Products of TTK Healthcare include cardiac care systems blood management systems renal care systems hospital accessories antibiotics Woodwards gripe water animal medicines etc. It also has a consumer products and food division manufacturing kiwi shoe polishes snacks etc. The company has collaborations with a number of foreign corporations such as London International KaliChemi Germany HatuICO Spain Nicholas Kiwi US etc. The products of the company are exported to the UK Egypt the US Germany Singapore Malaysia Carribean countries etc.The Pallavaram plant of the company has been accredited with the ISO 14002 certification by the Bureau of Indian Standards. Also one of the group companies TT Maps and Publications was merged with TTK Pharma in 1993.The company faced some rough weather in Jul.95 when the MRTPC ordered an inquiry against it for allegedly directing its wholesalers to keep a minimum stock of the companys products and defining their area of operations. During 199697 the company has tied up with M/s Mentholatum India Pvt Ltd.During the year 19992000 as a part of the restructuring programme the paper divison of the company has been disposed off and the merger of TTK Biomed has been approved by the Honble High Court Of Madras with retrospective effect from July 1 1999.In 200001 the company has vacated the bulk drug business segment by disposing of the Bulk Drugs Formulations facility at Hyderabad.The High Court Madras has approved the scheme of amlagamation between TTK Medical Devices Ltd. and the company.During the financial year 200304the Heart Valve division of the company has been awarded ISO 90012000 Certification by RWTUVGermany.

TTK Healthcare Ltd Share Price: ₹902.00 per share as on 23 Mar, 2023 04:01 PM
TTK Healthcare Ltd Market Capitalisation: ₹1,319.77Cr as of today
TTK Healthcare Ltd Listing date: 09 May, 1995
TTK Healthcare Ltd Chairperson Name: T T Jagannathan
OrganisationTTK Healthcare Ltd
HeadquartersChennai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Frequently Asked Questions

TTK Healthcare Ltd(TTKHLTCARE) share price today is ₹902.00 (last updated 23 Mar, 2023 at 04:01 PM)

  • Today’s highest price of TTK Healthcare Ltd(TTKHLTCARE) is ₹906.75.
  • Today’s lowest price of TTK Healthcare Ltd(TTKHLTCARE) is ₹882.00.
  • (last updated 23 Mar, 2023 at 04:01 PM)
Today’s traded volume of TTK Healthcare Ltd(TTKHLTCARE) is 3367.
Today’s market capitalisation of TTK Healthcare Ltd(TTKHLTCARE) is ₹1,319.77Cr.
TTK Healthcare Ltd(TTKHLTCARE)Price
52 Week High₹1125.00
52 Week Low₹667.00
  • (last updated 23 Mar, 2023 at 04:01 PM)
  • TTK Healthcare Ltd(TTKHLTCARE) share price is ₹902.00 (last updated 23 Mar, 2023 at 04:01 PM). It is down -19.82% from its 52 Week High price of ₹1125.00
    TTK Healthcare Ltd(TTKHLTCARE) share price is ₹902.00 (last updated 23 Mar, 2023 at 04:01 PM). It is up 35.23% from its 52 Week Low price of ₹667.00
    TTK Healthcare Ltd(TTKHLTCARE)Returns (%)
    1 Day Returns1.31%
    1 Month Returns-3.25%
    1 Year Returns6.10%
    3 Year Returns209.36%
    5 Year Returns-16.34%
    TTK Healthcare Ltd(TTKHLTCARE) share price is ₹902.00 and its price to earning (PE) is 0.00. A high PE ratio indicates that a share price is overvalued, or investors are expecting a high growth rate in the future.

    Indian stocks brokerage services are provided by INDmoney Private Limited. INDmoney Private Limited is carrying out the business of in respect to stock broking activities and also carries out the activities of depository participant. SEBI Registration No. INZ000305337 | SEBI Depository Participant Registration No. IN-DP-690-2022 Depository Participant ID: CDSL 12095500 | Trading and Clearing Member of NSE (90267, M70042) and BSE (6779)

    Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. The securities quoted are exemplary and not recommendatory. Past performance is not indicative of future returns.